Welcome to the Office of Cancer Survivorship Program, DCCPS
The NCI Office of Cancer Survivorship (OCS) works to enhance the quality and length of survival of all persons diagnosed with cancer and to prevent, minimize, or manage adverse effects of cancer and its treatment.
Meet the new OCS director,
Dr. Emily S. Tonorezos.
Spotlight
Publication
December 2020 — Consensus Study Report
National Academies releases consensus study report co-authored by OCS Director Dr. Emily Tonorezos: Childhood Cancer and Functional Impacts Across the Care Continuum.
Press Release
New treatments spur sharp reduction in lung cancer mortality rate, increasing number of lung cancer survivors.
Blog
Aug. 2020 — Cancer Currents Blog
Study offers insights on health problems among adolescent and young adult cancer survivors.
Blog
July 2020 — Cancer Currents Blog
Ovarian cancer studies aim to reduce racial disparities and improve outcomes.
Blog
July 2020 — Cancer Currents Blog
Helping cancer survivors cope with cancer-related anxiety and distress.
Funding Opportunities
About The Office of Cancer Survivorship
An individual is considered a cancer survivor from the time of diagnosis, through the balance of his or her life. There are many types of survivors, including those living with cancer and those free of cancer. This term is meant to capture a population of those with a history of cancer rather than to provide a label that may or may not resonate with individuals.
OCS works to promote a better understanding of unique needs of the growing population of cancer survivors, and to enhance our ability to address them.
Quick Links
Featured Graph and Statistic
Rates of New Cancer Cases by Sex and Race/Ethnicity
For all cancers combined, Black men have the highest rate of new cancer diagnoses.
Cancer Survivor Statistics
It is estimated that there are 16.9 million cancer survivors in the United States. This represents approximately 5.0% of the population.